FDA inspection
LGM Pharma Solutions LLC: FDA inspection ending Sep 16, 2002
FDA inspection 235682 · Voluntary Action Indicated (VAI) · Rosenberg, TX
Key facts
| Inspection ID | 235682 |
|---|---|
| Firm | LGM Pharma Solutions LLC |
| FEI number | 3017140511 |
| Address | 1000 Cole Ave |
| City | Rosenberg |
| State | TX |
| ZIP | 77471-3949 |
| Fiscal year | 2002 |
| Inspection end date | Sep 16, 2002 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs|OTC Drug Evaluation|Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data